These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 2978885)
1. In vivo-in vitro correlates of human rejection using flow cytometry with two-color fluorescence on peripheral blood mononuclear cells. Gross U; Thomas F; Matthews C; Thomas J; Cunningham P; Ritter T Transplant Proc; 1987 Feb; 19(1 Pt 2):1609-10. PubMed ID: 2978885 [No Abstract] [Full Text] [Related]
2. In situ antigenic modulation of human graft-infiltrating T cells is induced by OKT3 treatment. Caillat-Zucman S; Legendre C; Noel LH; Bach JF; Kreis H; Chatenoud L Transplant Proc; 1990 Aug; 22(4):1782. PubMed ID: 2143860 [No Abstract] [Full Text] [Related]
3. Expression of the IL-2 receptor (p55 and p75) on peripheral blood lymphocytes in renal transplant recipients. Fujiwara T; Sakagami K; Niguma T; Haisa M; Kawamura T; Kusaka S; Matsuoka J; Shiozaki S; Fujiwara T; Onoda T Transplant Proc; 1991 Feb; 23(1 Pt 1):256-9. PubMed ID: 1824979 [No Abstract] [Full Text] [Related]
4. Prophylactic use of the new monoclonal antibody BMA 031 in clinical kidney transplantation. Smely S; Weschka M; Hillebrand G; Dendorfer U; Krombach F; Kurrle R; Land W; Hammer C Transplant Proc; 1990 Aug; 22(4):1785-6. PubMed ID: 2143862 [No Abstract] [Full Text] [Related]
5. Prolonged and repeated courses of OKT3 after liver transplantation. Colledan M; Gridelli B; Rossi G; Caccamo L; Gatti S; Bonara P; Fassati LR; Ferla G; Maggi U; Reggiani P Transplant Proc; 1990 Aug; 22(4):1769-71. PubMed ID: 2143859 [No Abstract] [Full Text] [Related]
6. Degree of modulation of cell-surface CD3 by anti-lymphocyte therapies. Henell KR; Bakke A; Kenny TA; Kimball JA; Barry JM; Norman DJ Transplant Proc; 1991 Feb; 23(1 Pt 2):1070-1. PubMed ID: 1824886 [No Abstract] [Full Text] [Related]
7. The effect of major histocompatibility complex matching on renal pathology and OKT4/OKT8 (CD4/CD8) ratio in renal allograft rejection. Smart YC; Nanra RS; Hibberd AD; Burton RC Transplant Proc; 1987 Feb; 19(1 Pt 2):1627-8. PubMed ID: 3152632 [No Abstract] [Full Text] [Related]
8. The role of CD4+ and CD8+ T cells in rejection of class I MHC disparate renal allografts. Bradley JA; Gracie JA; Porteous C; Bolton EM Transplant Proc; 1991 Feb; 23(1 Pt 1):266-7. PubMed ID: 1899304 [No Abstract] [Full Text] [Related]
9. Natural killer cell subsets and alloresponsiveness in renal allograft recipients. Shabtai M; Waltzer WC; Pullis CK; Raisbeck AP; Malinowski K; Rapaport FT Transplant Proc; 1990 Aug; 22(4):1846-8. PubMed ID: 2143863 [No Abstract] [Full Text] [Related]
10. HLA class I (ABC) upregulation on peripheral blood CD3+/CD8+ T lymphocyte surface is a potential predictor of acute rejection in renal transplantation. Tian J; Shi WF; Zhang LW; Lu N; Cui XQ; Xian WH; Sun HB; Li EG; Geng LN; Zhang DZ; Zou X Transplantation; 2009 Dec; 88(12):1393-7. PubMed ID: 20029336 [TBL] [Abstract][Full Text] [Related]
11. Rapid T cell recovery after prophylactic ALG is associated with pancreas allograft rejection. Munn SR; Perkins JD Transplant Proc; 1990 Apr; 22(2):619. PubMed ID: 2139264 [No Abstract] [Full Text] [Related]
12. CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients. Posselt AM; Vincenti F; Bedolli M; Lantz M; Roberts JP; Hirose R Transplantation; 2003 Jul; 76(1):190-5. PubMed ID: 12865808 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo human T cell repertoire in kidney allograft rejection. Finn OJ; Miceli MC; Sanfilippo A; Bollinger RR; Barry TS Transplant Proc; 1988 Apr; 20(2):155-8. PubMed ID: 3284032 [No Abstract] [Full Text] [Related]
14. T gamma/delta lymphocytes in renal transplant recipients. Raasveld MH; Bloemena E; Surachno S; ten Berge RJ Nephrol Dial Transplant; 1992; 7(6):530-3. PubMed ID: 1377808 [TBL] [Abstract][Full Text] [Related]
15. Acute kidney graft rejection. A morphological and immunohistological study on "zero-hour" and follow-up biopsies with special emphasis on cellular infiltrates and adhesion molecules. Andersen CB; Ladefoged SD; Larsen S APMIS; 1994 Jan; 102(1):23-37. PubMed ID: 7513171 [TBL] [Abstract][Full Text] [Related]
16. Flow-cytometric monitoring of ATG therapy for steroid-resistant rejection. Clark KR; Forsythe JL; Shenton BK; Lennard TW; Proud G; Taylor RM Transplant Proc; 1992 Feb; 24(1):315. PubMed ID: 1531714 [No Abstract] [Full Text] [Related]